|Date||Analyst Firm||Analyst Name||Action||Rating||Action Price||Prior Price||Target|
You can purchase shares of Zynerba Pharmaceuticals (NASDAQ: ZYNE) through any online brokerage.
The latest price target for Zynerba Pharmaceuticals (NASDAQ: ZYNE) was reported by Needham on July 1, 2020. The analyst firm set a price target for 0.00 expecting ZYNE to fall to within 12 months (a possible -100.00% downside). 0 analyst firms have reported ratings in the last year.
The stock price for Zynerba Pharmaceuticals (NASDAQ: ZYNE) is $3.52 last updated Mon Nov 29 2021 21:00:03 GMT+0000 (Coordinated Universal Time).
There are no upcoming dividends for Zynerba Pharmaceuticals.
Zynerba Pharmaceuticals’s $Q3 earnings are confirmed for after-market on November 15, 2021.
There is no upcoming split for Zynerba Pharmaceuticals.
Zynerba Pharmaceuticals is in the Health Care sector and Pharmaceuticals industry. They are listed on the NASDAQ.